There are 1105 resources available
132MO - Anti-claudin18.2 (CLDN18.2) antibody-drug conjugate (ADC) IBI343 in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC): Updated results from a phase I study
Presenter: Jian Zhang
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 269O, 270O, 271O and LBA9
Presenter: Terence Friedlander
Session: Proffered Paper session: Genitourinary tumours
Resources:
Slides
Webcast
138MO - Baseline characteristics and molecular testing of patients with IDH1-mutated cholangiocarcinoma: Initial results from the phase IIIb ProvIDHe study
Presenter: Lorenza Rimassa
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session: Genitourinary tumours
Resources:
Webcast
Invited Discussant 132MO and 138MO
Presenter: Angela Lamarca
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Slides
Webcast
Q&A and discussion
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Webcast
73MO - Sotorasib (soto), panitumumab (pani), and FOLFIRI in first-line (1L) KRAS G12C–mutated metastatic colorectal cancer (mCRC): Regional analysis of safety and efficacy from CodeBreaK 101
Presenter: Toshiki Masuishi
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
74MO - mFOLFOX6 + bevacizumab + PD-1 monoclonal antibody in locally advanced MSS CRC (BASKETⅡ): A prospective, single-arm, open-label, phase II study
Presenter: Jun Huang
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 73MO and 74MO
Presenter: Jenny Seligmann
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Slides
Webcast
Q&A and discussion
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Webcast